Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3. Efficacy of Flavocoxid Compared With Naproxen in Subjects With Moderate-severe Osteoarthritis (OA) of the Knee

NCT00790985 is registered in ClinicalTrials.gov with Primus Pharmaceuticals as lead sponsor.

NCT NCT00790985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00790985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3. Efficacy of Flavocoxid Compared With Naproxen in Subjects With Moderate-severe Osteoarthritis (OA) of the Knee
Lead sponsor
Primus Pharmaceuticals
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2008
Completion date
August 31, 2008
Enrollment
223 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of knee